SCHEMBL25496397

SCHEMBL25496397

COc1ccc(CNc2ccc3cc(O)ccc3n2)c(OC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.53
CYP1A2 P05177 14/20 0.51
CYP3A4 P08684 14/20 0.51
CYP2C19 P33261 13/20 0.51
TSHR P16473 13/20 0.51
CYP2D6 P10635 12/20 0.51
USP2 O75604 9/20 0.51
LMNA P02545 6/20 0.51
CLK4 Q9HAZ1 6/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
HSD17B10 Q99714 5/20 0.51
ALDH1A1 P00352 5/20 0.51
CASP7 P55210 1/20 0.51
MAPK1 P28482 3/20 0.49
CYP2C9 P11712 3/20 0.49
APLNR P35414 1/20 0.49
ALOX15 P16050 5/20 0.48
GLA P06280 2/20 0.48
DHFR P00374 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30074346 1.00 MAOB (0.53) MAOBCYP1A2CYP3A4CYP2C19TSHR
SCHEMBL31366068 0.92 CYP1A2 (0.52) MAOBCYP1A2CYP3A4CYP2C19TSHR
SCHEMBL31091853 0.86 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C19TSHRCYP2D6
SCHEMBL31091838 0.83 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C19TSHRCYP2D6
SCHEMBL31091825 0.83 CYP1A2 (0.60) CYP1A2CYP3A4CYP2C19TSHRCYP2D6
SCHEMBL13713696 0.83 MAPT (0.57) CLK4MEN1KMT2AHSD17B10ALDH1A1
SCHEMBL3403276 0.78 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C19TSHRCYP2D6
SCHEMBL558386 0.77 PDGFRB (0.54) CYP1A2CYP3A4CYP2C19TSHRCYP2D6
SCHEMBL558073 0.77 FGFR3 (0.56) CYP1A2CYP3A4CYP2C19TSHRCYP2D6
SCHEMBL3267148 0.74 CYP1A2 (0.54) MAOBCYP1A2CYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117915956-A M6PR cell surface receptor binding compounds and conjugates 利西亚治疗公司 2024-04-19 CN disclosed
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates LYCIA THERAPEUTICS, INC. 2023-05-25 US disclosed
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates LYCIA THERAPEUTICS, INC. 2023-05-25 US disclosed
CN-115315263-A Cell surface receptor binding compounds and conjugates 利西亚治疗公司 2022-11-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158155-A1 Cell Surface Receptor Binding Compounds and Conjugates M6PR, ASGR1, IGF2R MAOB 2604/4885CYP1A2 4624/4885CYP3A4 3731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.